Stabilisation and Association Agreement between the EU and Croatia

Stabilisation and Association Agreement between the EU and Croatia Stabilisation and Association Agreement between the EU and Croatia

21.05.2015 Views

2915 Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives Manufacture from materials of any heading. However, the value of all the materials of heading Nos 2915 and 2916 used may not exceed 20 % of the ex-works price of the product Manufacture in which the value of all the materials used does not exceed 40 % of the exworks price of the product ex 2932 - Internal ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives Manufacture from materials of any heading. However, the value of all the materials of heading No 2909 used may not exceed 20 % of the exworks price of the product Manufacture in which the value of all the materials used does not exceed 40 % of the exworks price of the product - Cyclic acetals and internal hemiacetals and their halogenated, sulphonated, nitrated or nitrosated derivatives Manufacture from materials of any heading Manufacture in which the value of all the materials used does not exceed 40 % of the exworks price of the product 2933 Heterocyclic compounds with nitrogen heteroatom(s) only 2934 Nucleic acids and their salts; other heterocyclic compounds Manufacture from materials of any heading. However, the value of all the materials of headings Nos 2932 and 2933 used may not exceed 20 % of the ex-works price of the product Manufacture from materials of any heading. However, the value of all the materials of headings Nos 2932, 2933 and 2934 used may not exceed 20 % of the exworks price of the product Manufacture in which the value of all the materials used does not exceed 40 % of the exworks price of the product Manufacture in which the value of all the materials used does not exceed 40 % of the exworks price of the product 262

ex Chapter 30 Pharmaceutical products; except for: Manufacture in which all the materials used are classified within a heading other than that of the product. However, materials classified within the same heading may be used provided their value does not exceed 20 % of the ex-works price of the product 3002 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale Manufacture from materials of any heading, including other materials of heading No 3002. The materials of this description may also be used, provided their value does not exceed 20 % of the ex-works price of the product 263

ex Chapter 30<br />

Pharmaceutical<br />

products; except<br />

for:<br />

Manufacture in which<br />

all <strong>the</strong> materials used<br />

are classified within a<br />

heading o<strong>the</strong>r than that<br />

of <strong>the</strong> product.<br />

However, materials<br />

classified within <strong>the</strong><br />

same heading may be<br />

used provided <strong>the</strong>ir<br />

value does not exceed<br />

20 % of <strong>the</strong> ex-works<br />

price of <strong>the</strong> product<br />

3002 Human blood;<br />

animal blood<br />

prepared for<br />

<strong>the</strong>rapeutic,<br />

prophylactic or<br />

diagnostic uses;<br />

antisera <strong>and</strong> o<strong>the</strong>r<br />

blood fractions <strong>and</strong><br />

modified<br />

immunological<br />

products, whe<strong>the</strong>r<br />

or not obtained by<br />

means of<br />

biotechnological<br />

processes;<br />

vaccines, toxins,<br />

cultures of microorganisms<br />

(excluding yeasts)<br />

<strong>and</strong> similar<br />

products:<br />

- Products<br />

consisting of two<br />

or more<br />

constituents which<br />

have been mixed<br />

toge<strong>the</strong>r for<br />

<strong>the</strong>rapeutic or<br />

prophylactic uses<br />

or unmixed<br />

products for <strong>the</strong>se<br />

uses, put up in<br />

measured doses or<br />

in forms or<br />

packings for retail<br />

sale<br />

Manufacture from<br />

materials of any<br />

heading, including<br />

o<strong>the</strong>r materials of<br />

heading No 3002. The<br />

materials of this<br />

description may also be<br />

used, provided <strong>the</strong>ir<br />

value does not exceed<br />

20 % of <strong>the</strong> ex-works<br />

price of <strong>the</strong> product<br />

263

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!